Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
An update with molecular analysis of the phase 3 CATNON trial demonstrates that the benefit of adjuvant temozolomide (TMZ) is dependent on the mutational status of isocitrate dehydrogenase (IDH) .
…